Submitted by Anonymous (not verified) on 14 April 2026 - 15:00
Orphan designation: resecabtagene autoleucel Treatment of systemic sclerosis, 21/11/2025 Positive
Source:
Orphan designation: resecabtagene autoleucel Treatment of systemic sclerosis, 21/11/2025 Positive